Gene · 6891
Papers2,915
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,915
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Metabolism-Related Gene Prognostic Index for Prediction of Response to Immunotherapy in Lung Adenocarcinoma. | Int J Mol Sci | 2022 | 36293001 | PubTator, text mining | PubMed |
| Nanomedicine-Based Gene Delivery for a Truncated Tumor Suppressor RB94 Promotes Lung Cancer Immunity. | Cancers (Basel) | 2022 | 36291878 | PubTator, text mining | PubMed |
| The type 1 diabetes gene TYK2 regulates β-cell development and its responses to interferon-α. | Nat Commun | 2022 | 36289205 | PubTator, text mining | PubMed |
| Antigen peptide transporters are upregulated in squamous cell carcinoma of the oral tongue and show sex-specific associations with survival. | Oncol Lett | 2022 | 36276482 | PubTator, text mining | PubMed |
| Meta-analysis of active tuberculosis gene expression ascertains host directed drug targets. | Front Cell Infect Microbiol | 2022 | 36275035 | PubTator, text mining | PubMed |
| Engineering neoantigen vaccines to improve cancer personalized immunotherapy. | Int J Biol Sci | 2022 | 36263174 | PubTator, text mining | PubMed |
| Study on the prognosis, immune and drug resistance of m6A-related genes in lung cancer. | BMC Bioinformatics | 2022 | 36261786 | PubTator, text mining | PubMed |
| The Role of Dynamic DNA Methylation in Liver Transplant Rejection in Children. | Transplant Direct | 2022 | 36259078 | PubTator, text mining | PubMed |
| Ubiquitin-specific peptidase 10, a deubiquitinating enzyme: Assessing its role in tumor prognosis and immune response. | Front Oncol | 2022 | 36248971 | PubTator, text mining | PubMed |
| The causal relationship between neuromyelitis optica spectrum disorder and other autoimmune diseases. | Front Immunol | 2022 | 36248893 | PubTator, text mining | PubMed |
| PTPRD/PTPRT mutation as a predictive biomarker of immune checkpoint inhibitors across multiple cancer types. | Front Immunol | 2022 | 36248841 | PubTator, text mining | PubMed |
| Characterizing the Crosstalk of NCAPG with Tumor Microenvironment and Tumor Stemness in Stomach Adenocarcinoma. | Stem Cells Int | 2022 | 36238529 | PubTator, text mining | PubMed |
| Micro-RNA193a-3p Inhibits Breast Cancer Cell Driven Growth of Vascular Endothelial Cells by Altering Secretome and Inhibiting Mitogenesis: Transcriptomic and Functional Evidence. | Cells | 2022 | 36230929 | PubTator, text mining | PubMed |
| PRC2-Mediated Epigenetic Suppression of Type I IFN-STAT2 Signaling Impairs Antitumor Immunity in Luminal Breast Cancer. | Cancer Res | 2022 | 36222718 | PubTator, text mining | PubMed |
| Prognostic value of TIGIT in East Asian patients with solid cancers: A systematic review, meta-analysis and pancancer analysis. | Front Immunol | 2022 | 36211383 | PubTator, text mining | PubMed |
| The regulatory role of long non- coding RNAs as a novel controller of immune response against cancer cells. | Mol Biol Rep | 2022 | 36207500 | PubTator, text mining | PubMed |
| A transcriptomics-based meta-analysis identifies a cross-tissue signature for sarcoidosis. | Front Med (Lausanne) | 2022 | 36203777 | PubTator, text mining | PubMed |
| T cell Repertoire Profiling and the Mechanism by which HLA-B27 Causes Ankylosing Spondylitis. | Curr Rheumatol Rep | 2022 | 36197645 | PubTator, text mining | PubMed |
| The lysosomal transporter TAPL has a dual role as peptide translocator and phosphatidylserine floppase. | Nat Commun | 2022 | 36195619 | PubTator, text mining | PubMed |
| Mechanisms of tumor resistance to immune checkpoint blockade and combination strategies to overcome resistance. | Front Immunol | 2022 | 36189283 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6891/papers?page=20